SCHEMBL2859019

SCHEMBL2859019

CC(C)(C)OC(=O)CC(O)c1cccs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
KEAP1 Q14145 1/20 0.41
ALOX5 P09917 1/20 0.38
HTR1A P08908 1/20 0.38
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CTSK P43235 2/20 0.37
CTSS P25774 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2D6 P10635 1/20 0.36
REN P00797 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2863369 1.00 CES2 (0.41) CES2CES1KEAP1ALOX5HTR1A
SCHEMBL2859016 1.00 CES2 (0.41) CES2CES1KEAP1ALOX5HTR1A
SCHEMBL2871143 0.83 CES2 (0.44) CES2CES1KEAP1ALOX5HTR1A
SCHEMBL2871139 0.83 CES2 (0.44) CES2CES1KEAP1ALOX5HTR1A
SCHEMBL97784 0.83 CES2 (0.44) CES2CES1KEAP1ALOX5HTR1A
SCHEMBL7410328 0.82 POLB (0.40) CES2CES1KEAP1ALOX5RAB9A
SCHEMBL7407275 0.82 POLB (0.40) CES2CES1KEAP1ALOX5RAB9A
SCHEMBL27274197 0.80 CTSK (0.37) CES2CES1KEAP1ALOX5RAB9A
SCHEMBL2859012 0.80 ALDH1A1 (0.43) CES2CES1KEAP1ALOX5RAB9A
SCHEMBL2874009 0.80 TSHR (0.42) CES2CES1KEAP1ALOX5HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659409-B2 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2010-02-09 US disclosed
US-20050107621-A1 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2005-05-19 US disclosed
EP-1486493-A1 3-HYDROXY-3-(2-THIENYL)PROPIONAMIDE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING 3-AMINO-1-(2-THIENYL)-1-PROPANOL COMPOUND THEREFROM Mitsubishi Chemical Corporation (JP) 2004-12-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107621-A1 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same APEH, AADAC, KMO CES2 719/4885CES1 126/4885KEAP1 2855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.